your market intelligence analyst
Search Results
2 results
Your search is now limited to «Melanoma» expert search.
Your search is now limited to only one Source. To return to results from all sources click here.
Healio News 05/30/2020 07:53
Adjuvant pembrolizumab taken for up to 1 year conferred a durable, clinically meaningful RFS benefit for patients with resected high-risk stage III melanoma, according to study results presented during the ASCO20 Virtual Scientific Program. The RFS improvement — observed at 3-year median follow-up of the randomized, phase 3 EORTC 1325/KEYNOTE-054 trial — remained consistent across subgroups, researchers noted. “In the old era, for about 50 years, we tried to define the role of adjuvant therapy for stage III melanoma,” Alexander M.M. Eggermont, MD, PhD, FASCO, professor.

Health Care

Health and Wellness

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies


Information Technologies

Job Titles

Legal and Regulatory

Political Entities


Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications